♟️ Friday 30 October 2026 Fri, 30 Oct 2026

Australian Rare Earths has produced its first Mixed Rare Earth Hydroxide at the Koppamurra pilot plant while extending an interpreted carbonatite system at Overland by roughly 5km. The operating progress comes with two important qualifiers: Koppamurra still needs further product refinement and Overland assays remain pending.

Alexium has lifted production efficiency and September revenue, but ended the quarter with only US$337,000 of cash and available funding. The company remains dependent on further shareholder loans while targeting positive operating cash flow in June 2027.

Doctor Care Anywhere’s Q3 revenue rose 16% to £11.3 million as its weight-management business delivered its first full quarter, lifting subscription revenue to 19% of the total. The unaudited update also shows modest consultation growth, higher cash and three new distribution partnerships.

Aurora Labs has moved another step from propulsion development toward commercial production, securing AS9100D certification and its first US engine order while customer enquiries expand. But with only A$1.148 million in cash at quarter-end and 1.5 quarters of funding estimated, the A$6 million raise is central to the next phase.

Infinity Mining has signed a partially binding term sheet to sell its Cangai Copper Project for $1.0 million cash, plus the return of approximately $0.2 million in rehabilitation security. The proposed deal would leave Infinity with four years of rights to test and process Cangai slag while its exploration portfolio produces high-grade but early-stage results.

Barramundi’s portfolio suffered its worst reported year in decades, with a NZ$42.9 million loss and an adjusted NAV return of -18.2% against a 9.2% benchmark gain. The board is negotiating a new management agreement with Fisher Funds while imposing tighter diversification and risk limits.

Blue Energy is positioning its Queensland gas portfolio for potential demand from LNG exporters under proposed federal reservation rules, while seeking a farm-in partner for ATP 854. The company ended September with A$3.2 million in unaudited cash, no debt and a more cautious approach to Sapphire spending.

Quantum Graphite has taken Uley 2 FEED work to 80% completion while finalising its Oman refinery plans and revised financing structure. The progress comes alongside A$1.272 million of quarterly operating and investing outflows, just A$50,000 of reported quarter-end cash and estimated funding of 1.33 quarters.

Clinuvel has submitted NEURACTHEL Instant for regulatory review in three initial European Union markets, opening a potential pathway for its second pharmaceutical product. The decentralised review is expected to take 300 days, excluding clock stops, but the product is not yet approved anywhere.

The Calmer Co. posted record Q1 FY27 revenue of A$2.44 million, powered by a sharp lift in US wholesale orders and continued Coles and Woolworths growth. But with A$953,000 in cash against quarterly operating outflows of A$755,000, the kava company remains dependent on further funding and sustained sales momentum.

Energy One has completed its acquisition of European energy software business GMSL, issuing 7,089,780 shares to Fluxys in the process. Fluxys is now Energy One’s largest shareholder and has secured a board seat through nominee director Erik Vennekens.

Waratah Minerals has expanded its Spur Gold Project across multiple targets, led by a 46-metre intercept grading 7.27g/t gold at Consols. The company also completed the Ironclad lease acquisition and ended the quarter with A$44.46 million in cash and listed investments.

WhiteRock Lithium has completed its 19,481-metre Spodumene Mountain drilling campaign, with assays from the first 17 holes confirming thick, high-grade lithium intersections. The ASX-listed explorer is now working towards a maiden Mineral Resource Estimate in the first half of 2027, subject to further assays and geological modelling.

ImpediMed lifted quarterly revenue and recurring revenue, but weaker-than-expected BCRL sales and a near-total sales team rebuild have put its path to cash-flow break-even under pressure. The company ended September with $11.6 million in cash and 4.7 quarters of funding at the quarter’s operating burn.

Galan Lithium says first lithium chloride concentrate sales from Hombre Muerto West remain on track for Q4 2026, with plant data supporting the planned product quality. Earthworks have also started to lift Phase 1 capacity to 5.2ktpa, although development spending leaves the company with a measured funding runway under its Appendix 5B calculation.

Capstone Copper delivered a record eighth consecutive quarter of adjusted EBITDA, while strong copper prices drove a sharp reduction in net debt. But production is now expected at the low end of 2026 guidance, costs at the high end and capital spending has risen by US$40 million.

Murray Cod Australia has posted record quarterly sales and expanded into hundreds of Woolworths and Coles stores, but the growth story still depends on turning distribution gains into recurring cash receipts. Underlying operating cash outflow remained A$4.27 million after excluding a one-off R&D tax incentive, while August fish mortality exposed an operational risk.

Dalaroo Metals has expanded its Bondoukou campaign to a fully funded 12,000 metres after early Wilfred assays included 18 metres at 7.31 g/t gold. The September quarter also delivered four new Greenland prospects, stronger Watheroo copper-nickel targets and an A$2.5 million capital raising.

Sky Metals has backed Tallebung with a strong pre-feasibility study, a 32.7-million-tonne resource and a new drilling campaign aimed at extending the mine life. The economics are compelling on the company’s assumptions, but financing, approvals and resource conversion remain the milestones between a study and a mine.

Australian Vanadium has moved its flagship project closer to an Optimised Feasibility Study while adding new industrial battery opportunities with Alcoa. But the September quarter also reduced cash to $12.4 million, leaving an estimated 2.5 quarters of funding at the reported spending rate.

Magnum Mining has completed its main Piracanjuba North drilling campaign and narrowed the Brazilian rare earths project to a 32.5 square kilometre priority zone ahead of a maiden resource estimate. The progress comes with a sharper constraint: A$2.0 million in cash covers only about 1.19 quarters at the latest spending rate.

True North Copper has extended Mt Oxide’s exploration story and lifted Cloncurry’s contained resource to 204kt CuEq, while an $18.75 million equity raise helps fund its next phase. The quarter also highlights the company’s continuing dependence on capital markets, with reported cash covering less than two quarters of current outgoings.

Count has reported a strong start to FY2027, with first-quarter revenue up 23.2%, underlying EBITA up 66.6% and funds under management reaching $6.7 billion. The group is also pursuing a 30% stake in Brisbane accounting and advice firm Apiary, although the purchase price remains undisclosed and completion requires ACCC approval.

Environmental Clean Technologies has produced its first MXene on a US Flash Joule Heating reactor, marking a technical step in its defence materials strategy. The harder work now is proving repeatability, performance and customer qualification while building a separate PFAS pilot.